TELEHEALTH · PROVIDER COMPARISON
Winona vs Midi: Compounded Convenience or Insurance-Based Care?
One ships compounded hormones on a subscription. One bills your insurance for a clinician visit. The price tags are not measuring the same thing.
By Franky Wilder · Reviewed by Michael Peters, MD · Last reviewed: September 2026 · 9 min read
✓ Medically Reviewed by Michael Peters, MD (Retired Physician, Metabolic & Hormonal Health)
NOT MEDICAL ADVICE
This comparison is for educational purposes only. It does not constitute a medical recommendation, diagnosis, or treatment plan. The right choice depends on your individual health history, current medications, and clinical profile. Consult a qualified healthcare provider before making any changes to your health regimen.
TL;DR
- Winona and Midi Health both treat perimenopause by telehealth, but on opposite models: Winona ships largely compounded hormone formulations on a cash-pay subscription, while Midi runs insurance-billed clinician visits prescribing FDA-approved therapy.
- Winona's lane is hormone optimization — estradiol, progesterone, testosterone — with subscription convenience. Midi's lane is wider: HRT plus non-hormonal and metabolic care, including GLP-1 conversations where appropriate.
- Compounded vs FDA-approved is a real clinical distinction, not a marketing one — it is the first question to ask either prescriber.
- Both require physician consultation before any prescription.
- The honest read: match the platform to the disruption that's loudest for you right now — not to whoever ranks first in a search result.
WHAT THIS IS NOT
- Not a medical recommendation. The right platform depends on your individual health history.
- Not a ranking based on payment. Both Winona and Midi Health are vetted affiliate partners of ours — which is exactly why this page has to be harder on both of them, not softer.
- Not a substitute for working with a provider who knows your history.
Two Models, One Decision
Winona and Midi Health both treat perimenopause by telehealth — but Winona ships largely compounded hormone formulations on a cash-pay subscription, while Midi runs insurance-billed clinician visits prescribing FDA-approved therapy. Those two sentences carry the entire decision, and most pages comparing these platforms bury them under feature tables.
The compounded-versus-approved axis matters more than the branding. It determines how your medication is made, how its consistency is verified, how it is paid for, and what your clinician should be discussing with you before the first refill. Neither answer is automatically wrong — but you should be choosing it on purpose.
How They Compare
| Feature | Midi Health | Winona |
|---|---|---|
| Primary focus | Hormones + metabolic health | Hormone replacement therapy |
| Care model | Scheduled clinician visits, booked follow-up | Subscription with physician evaluation and ongoing messaging |
| Formulations | FDA-approved products | Largely compounded bioidentical formulations |
| Prescribes estrogen / progesterone | Yes / Yes | Yes / Yes |
| Prescribes testosterone (women) | Yes | Yes |
| Prescribes GLP-1 | Yes, where clinically appropriate | No |
| Insurance | Bills many major plans (varies by state and plan) | Cash-pay — not billed to insurance |
| HSA/FSA | Typically eligible — confirm with your plan | Typically eligible — confirm with your plan |
| Vetted partner | ✅ Yes | ✅ Yes |
| Next step | Review the Midi Care Path → | Review the Hormone Protocol → |
Midi Health: Insurance-Based Care, Wider Lane
Midi Health operates like a specialist clinic on a screen: scheduled video visits with clinicians trained in perimenopause and menopause care, billed to many major insurance plans. Its prescribing stays within FDA-approved hormone therapy — estradiol, progesterone, testosterone where appropriate — alongside non-hormonal options, labs where indicated, and metabolic care including GLP-1 conversations where clinically appropriate.
For women navigating hormonal symptoms tangled together with body-composition change — which perimenopause produces constantly — the width of that lane means one clinical relationship instead of two. And the insurance model changes the economics of staying in care: follow-up visits that bill like healthcare instead of renewing like a subscription. If you have spent years feeling dismissed in generalist visits, a clinician whose entire caseload is this decade is the structural fix, not a luxury.
Hormone therapy and GLP-1 medications are prescription-only, and not appropriate for everyone. Candidacy is determined by a licensed physician based on your individual history.
This article contains some affiliate links. Menopossy may earn a commission if you purchase through them — at no additional cost to you. This does not affect our editorial position. Evidence tier labels reflect our independent assessment of the research, not the commercial relationship.
Midi Health — Insurance-Based Menopause Care
Menopossy gives you the clarity. Midi gives you access to care — a clinician whose entire practice is the decade your twelve-minute annual visit keeps skipping.
THE PATH: A scheduled visit with a menopause-trained clinician, billed to insurance where covered. Evaluation first — prescriptions only where clinically appropriate.
Midi connects you with clinicians who specialize in perimenopause and menopause, coordinate labs where indicated, and build a follow-up plan — hormonal, non-hormonal, and metabolic lanes under one roof.
Review the Midi Care Path →Tier A — Clinical Care | Affiliate
Winona: The Hormone-Forward Subscription
Winona is purpose-built for one thing: hormone replacement for women in perimenopause and menopause. Its physicians evaluate your profile and — where clinically appropriate — prescribe bioidentical estradiol, progesterone, and testosterone, much of it as compounded formulations prepared by its partner pharmacies, shipped on a subscription with ongoing physician messaging. If you have been told your labs are normal but still feel the disruption, Winona's clinicians are trained to work the normal-versus-optimal distinction.
The compounded model deserves the honest sentence most comparison pages skip: compounded preparations offer dose and delivery flexibility that approved products sometimes cannot, and in exchange they give up the individual FDA review and batch standardization that approved products carry. Clinical guidelines generally favor FDA-approved therapy where it meets the need, reserving compounding for cases where it does not. That is not a disqualification of Winona — it is the exact question to put to their physician in your consult, and a good one will welcome it.
Hormone replacement therapy is not appropriate for everyone. Candidacy depends on your personal and family health history. A physician consultation is required before any prescription.
Winona — Physician-Led Hormone Therapy
For women whose vasomotor symptoms, cognitive shifts, and sleep disruption trace back to estradiol withdrawal — Winona's physician-led MHT protocol addresses the biological root, not the symptoms in isolation.
THE PROTOCOL: Restore the estradiol signal that perimenopause removed. Tier A: most evidence-backed intervention for vasomotor symptoms per Menopause Society guidelines. Physician consultation required — candidacy is individual.
Winona connects you with a licensed physician who evaluates your hormone profile and — where clinically appropriate — prescribes bioidentical estradiol, progesterone, and testosterone. Delivered to your door.
Review the Hormone Protocol →Tier A — Clinical Guidelines | Affiliate
How to Choose Between Them
You do not need to become a clinician to make this call. You need to know which disruption is loudest right now, how you want your medication made, and how you want to pay. Neither of these is a verdict on you. It is a routing decision.
CONSIDER MIDI HEALTH IF
- Metabolic change — body composition, weight — is sitting alongside the hormonal symptoms, and you want both pathways under one roof.
- You want FDA-approved formulations and insurance billing doing the work your premiums already paid for.
- You prefer care structured as scheduled visits with booked follow-up, the way a clinic runs.
CONSIDER WINONA IF
- Your loudest signals are hormonal — vasomotor, sleep, cognitive, mood, intimacy — and you want a platform built specifically around hormone optimization.
- Subscription convenience and ongoing physician messaging fit how you want to manage a protocol, and cash-pay works for you.
- You understand the compounded-versus-approved distinction and a physician confirms it fits your case.
These are considerations, not directives. The right choice depends on your clinical profile and a conversation with a physician.
Questions to Bring to Your First Appointment
Whichever platform you start with, the consult goes better when the questions are already written down. You are not there to be managed. You are there to be evaluated — and good questions shift the dynamic from dismissal to data.
- "Based on my history, am I a candidate for hormone therapy — and what would rule me out?"
- "Is what you would prescribe me FDA-approved or compounded — and why is that the right choice for my case?"
- "Which hormones would you assess before prescribing — estradiol, progesterone, testosterone, thyroid?"
- "How do you decide between transdermal and oral delivery for someone with my profile?"
- "If my labs read 'normal,' how do you weigh that against the symptoms I'm describing?"
- "What follow-up and monitoring schedule do you use once a protocol starts?"
- "If metabolic change is also a concern, is GLP-1 something you prescribe — or would you refer?"
- "What would make you change or stop a protocol?"
DO NOT ACCEPT
- "You're too young for this." Midlife hormonal change commonly begins in the early-to-mid 40s — years before the final period.
- "Your labs are normal, so there's nothing to treat." Normal is a population range, not your baseline.
- "Compounded is exactly the same as FDA-approved." It is the same molecule with a different verification standard — a distinction your prescriber should explain, not wave away.
- "Hormone therapy is too risky to discuss." Risk is individual and worth an actual conversation — not a blanket refusal.
- A prescription handed over with no plan for follow-up, monitoring, or adjustment.
You are entitled to a clinical conversation, not a dismissal.
The Bottom Line
VETTED PARTNER — INSURANCE-BASED CARE
Midi Health: the wider door — FDA-approved therapy, insurance billing where covered, and hormonal plus metabolic care in one clinical relationship.
VETTED PARTNER — HORMONAL OPTIMIZATION
Winona: the focused door — physician-led hormone replacement on a convenient subscription, for women whose question is squarely hormonal and who choose the compounded model knowingly.
These platforms are not rivals so much as different doors into the same goal — getting your biology evaluated by someone who treats midlife change as real. Midi is the wider door, and the covered one. Winona is the focused door with the subscription convenience. Either way, the move that matters is walking through one of them with data instead of guesses.
If you're not sure which applies to you — the Bio-Audit maps the full picture. For how Midi stacks against the speed-first model, read Alloy vs Midi, or compare all providers.
IMPORTANT
If you are experiencing chest pain, severe acute symptoms, or a medical emergency — go to an ER. This page is not emergency care.
Frequently Asked Questions
What does 'compounded' hormone therapy actually mean?
Compounded hormones are mixed by a pharmacy for an individual prescription rather than manufactured as an FDA-approved product. The hormones themselves are the same molecules, but compounded preparations are not individually FDA-reviewed for dose consistency the way approved products are. That difference — flexibility versus standardization — is the real axis of the Winona vs Midi decision, and worth discussing with any prescriber.
Does Winona prescribe GLP-1 medications?
No. Winona specializes in hormone replacement therapy — estradiol, progesterone, and testosterone. If GLP-1 prescribing is also a priority, Midi Health offers both services. Confirm clinical candidacy with a licensed physician.
Is telehealth hormone therapy covered by HSA or FSA?
Both Winona and Midi Health are typically HSA/FSA eligible as they provide physician consultations and prescription medications. Midi additionally bills many major insurance plans for its visits. Confirm with your plan administrator as eligibility varies by plan and state.
Do I need to stop seeing my current doctor to use Winona or Midi?
No. Both platforms function as specialist telehealth services, not primary care replacements. Your existing provider relationship should continue. These platforms work best as additions to your current care.
Sources
The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause, 2022;29(7):767–794.
Why this matters: the Tier A evidence base for hormone therapy in vasomotor symptoms — and the guideline preference for FDA-approved products where they meet the clinical need.
National Academies of Sciences, Engineering, and Medicine. The Clinical Utility of Compounded Bioidentical Hormone Therapy. The National Academies Press, 2020.
Why this matters: the most rigorous independent review of compounded hormone therapy — the evidence behind treating compounded-versus-approved as a real clinical distinction.
U.S. Food and Drug Administration — approved menopausal hormone therapy products, and FDA guidance on human drug compounding. fda.gov.
Why this matters: what FDA approval covers, what compounding regulation covers instead, and why the two verification standards differ.
This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. Franky Wilder is not a licensed physician or clinician. Always consult a qualified healthcare provider before making changes to your health regimen. Menopossy maintains affiliate relationships with Winona and Midi Health. Our editorial content is never influenced by commercial relationships.